ID

34469

Descripción

Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.; ODM derived from: https://clinicaltrials.gov/show/NCT02050542

Link

https://clinicaltrials.gov/show/NCT02050542

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 11/2/20 11/2/20 - Christian Arras
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient from 45 to 75 years old;
Descripción

ID.1

Tipo de datos

boolean

serum level of psa > 4,0 ng / ml;
Descripción

ID.2

Tipo de datos

boolean

multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
Descripción

ID.3

Tipo de datos

boolean

no opposition of the patient notified in the medical record
Descripción

ID.4

Tipo de datos

boolean

patient member in a national insurance scheme.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate biopsy;
Descripción

ID.6

Tipo de datos

boolean

suspicious digital rectal examination;
Descripción

ID.7

Tipo de datos

boolean

serum psa > 20,0 ng / ml;
Descripción

ID.8

Tipo de datos

boolean

treatment with 5 alpha reductase inhibitor during the last 3 months;
Descripción

ID.9

Tipo de datos

boolean

untreated urinary infection
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient from 45 to 75 years old;
boolean
ID.2
Item
serum level of psa > 4,0 ng / ml;
boolean
ID.3
Item
multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
boolean
ID.4
Item
no opposition of the patient notified in the medical record
boolean
ID.5
Item
patient member in a national insurance scheme.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
previous prostate biopsy;
boolean
ID.7
Item
suspicious digital rectal examination;
boolean
ID.8
Item
serum psa > 20,0 ng / ml;
boolean
ID.9
Item
treatment with 5 alpha reductase inhibitor during the last 3 months;
boolean
ID.10
Item
untreated urinary infection
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial